Effect of calibration on computerized analysis of prostate lesions using quantitative dynamic contrast-enhanced magnetic resonance imaging

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6514, Issue PART 1, 2007, Pages

  Vos, Pieter C ^a   Hambrock, Thomas ^a   Fütterer, Jurgen J ^a   Van De Kaa, C A Hulsbergen ^a   Barentsz, Jelle ^a   Huisman, Henkjan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diagnostic task: diagnosis; Methods: quantitative image analysis; Modalities: magnetic resonance imaging

Indexed keywords

CALIBRATION; COMPUTER AIDED DIAGNOSIS; HISTOLOGY; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; PATIENT MONITORING; PHARMACOKINETICS; RADIOLOGY;

ADENOCARCINOMA; COMPUTERIZED ANALYSIS; HISTOPATHOLOGY; MALIGNANT LESIONS; PATIENT CALIBRATION METHODS; PROSTATE CANCER; PROSTATE LESIONS;

ONCOLOGY;

EID: 35248827294     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.709357     Document Type: Conference Paper

References (21)

1. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, and M. Thun, "Cancer statistics, 2006.," CA Cancer J Clin 56(2), pp. 106-30, 2006.
2. H. Huisman, M. Engelbrecht, and J. Barentsz, "Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate.," J Magn Reson Imaging 13(4), pp. 607-14, 2001.
3. M. Engelbrecht, H. Huisman, R. Laheij, G. Jager, G. van Leenders, C. Hulsbergen-Van De Kaa, J. de la Rosette, J. Blickman, and J. Barentsz, "Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.," Radiology 229(1), pp. 248-54, 2003.
4. A. Padhani, C. Gapinski, D. Macvicar, G. Parker, J. Suckling, P. Revell, M. Leach, D. Dearnaley, and J. Husband, "Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA.," Clin Radiol 55(2), pp. 99-109, 2000.
5. K. Ogura, S. Maekawa, K. Okubo, Y. Aoki, T. Okada, K. Oda, Y. Watanabe, C. Tsukayama, and Y. Arai, "Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results.," Urology 57(4), pp. 721-6, 2001.
6. J. Futterer, S. Heijmink, T. Scheenen, J. Veltman, H. Huisman, P. Vos, C. de Kaa, J. Witjes, P. Krabbe, A. Heerschap, and J. Barentsz, "Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging.," Radiology 241(2), pp. 449-58, 2006.
7. H. Huisman, J. Veltman, C. Boetes, N. Karssemeijer, and J. Barentsz, "Diagnostic pharmacokinetic breast mr.," Magnetic Resonance in Medicine, 2007.
8. H. Huisman, J. Veltman, C. Boetes, N. Karssemeijer, H. Blickman, and J. Barentsz. "Computer-aided diagnosis of breast mri using pharmacokinetic modeling.," RSNA, 2006.
9. P. Vos, T. Hambrock, J. Fütterer, C. Hulsbergen-van De Kaa, J. Barentsz, and H. Huisman, "Computerized analysis of prostate lesions using quantitative dynamic contrast enhanced magnetic-resonance imaging.," Medical Phycics, 2007.
10. A. Bono, N. Celato, V. Cova, M. Salvadore, S. Chinetti, and R. Novario, "Microvessel density in prostate carcinoma.," Prostate Cancer Prostatic Dis 5(2), pp. 123-7, 2002.
11. D. Kovar, M. Lewis, and G. Karczmar, "A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues.," J Magn Reson Imaging 8(5), pp. 1126-34, 1998.
12. K. Donahue, R. Weisskoff, D. Parmelee, R. Callahan, R. Wilkinson, J. Mandeville, and B. Rosen, "Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction.," Magn Reson Med 34(3), pp. 423-32, 1995.
13. P. Tofts, G. Brix, D. Buckley, J. Evelhoch, E. Henderson, M. Knopp, H. Larsson, T. Lee, N. Mayr, G. Parker, R. Port, J. Taylor, and R. Weisskoff, "Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.," J Magn Reson Imaging 10(3), pp. 223-32, 1999.
14. G. Liney, P. Gibbs, C. Hayes, M. Leach, and L. Turnbull, "Dynamic contrast-enhanced MRI in the differentiation of breast tumors: user-defined versus semi-automated region-of-interest analysis.," J Magn Reson Imaging 10(6), pp. 945-9, 1999.
15. C. Hayes, A. Padhani, and M. Leach, "Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging.," NMR Biomed 15(2), pp. 154-63, 2002.
16. D. Collins and A. Padhani, "Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges.," IEEE Eng Med Biol Mag 23(5), pp. 65-83, 2004.
17. M. Stoutjesdijk, J. Futterer, C. Boetes, L. van Die, G. Jager, and J. Barentsz, "Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging.," Invest Radiol 40(6), pp. 355-62, 2005.
18. C. Rutter, "Bootstrap estimation of diagnostic accuracy with patient-clustered data.," Acad Radiol 7(6), pp. 413-9, 2000.
19. K. Hittmair, G. Gomiscek, K. Langenberger, M. Recht, H. Imhof, and J. Kramer, "Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI.," Magn Reson Med 31(5), pp. 567-71, 1994.
20. C. Kuhl, P. Mielcareck, S. Klaschik, C. Leutner, E. Wardelmann, J. Gieseke, and H. Schild, "Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?," Radiology 211(1), pp. 101-10, 1999.
21. A. Padhani, "MRI for assessing antivascular cancer treatments.," Br J Radiol 76 Spec No 1, pp. S60-80, 2003.